Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024

Rhea-AI Summary

Fractyl Health (Nasdaq: GUTS), a metabolic therapeutics company focusing on innovative treatments for obesity and type 2 diabetes, has announced it will release its second quarter 2024 financial results and provide business updates on August 14, 2024, at 4:30 p.m. ET. The company will host a live webcast of the conference call, which can be accessed through the 'Events' section of Fractyl's investor relations website. For those unable to attend the live event, an archived version of the webcast will be made available for replay on the company's website.

News Market Reaction – GUTS

-9.77%

-9.77% Session move

In the trading session that priced this news, GUTS declined 9.77%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced it will report financial results for the second quarter 2024 and provide business updates on Wednesday, August 14, 2024, at 4:30 p.m. ET.

A live webcast of the conference call can be accessed in the “Events” section of Fractyl’s website at https://ir.fractyl.com/. The webcast will be archived and available for replay following the live event.

About Fractyl Health

Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health’s goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. Fractyl Health is based in Burlington, MA. For more information, visit www.fractyl.com or www.twitter.com/FractylHealth.

Contacts 

Corporate Contact 
Lisa Davidson, Chief Financial Officer 
ir@fractyl.com, 781.902.8800

Media Contact 
Jessica Cotrone, Corporate Communications
jcotrone@fractyl.com, 978.760.5622

Investor Contact
Stephen Jasper Gilmartin Group
stephen@gilmartinir.com, 619.949.3681

FAQ

When will Fractyl Health (GUTS) report its Q2 2024 financial results?

Fractyl Health (GUTS) will report its second quarter 2024 financial results on August 14, 2024, at 4:30 p.m. ET.

How can I access Fractyl Health's (GUTS) Q2 2024 earnings call?

You can access Fractyl Health's Q2 2024 earnings call via a live webcast in the 'Events' section of the company's website at https://ir.fractyl.com/.

What is Fractyl Health's (GUTS) primary focus as a company?

Fractyl Health (GUTS) is a metabolic therapeutics company focused on pioneering new approaches to treat root causes of obesity and type 2 diabetes.

Will there be a replay available for Fractyl Health's (GUTS) Q2 2024 earnings call?

Yes, the webcast of Fractyl Health's Q2 2024 earnings call will be archived and available for replay on the company's website following the live event.